Regulation of TERRA on telomeric and mitochondrial functions in IPF pathogenesis

Male 0301 basic medicine Aging Apoptosis Diseases of the respiratory system Mice 03 medical and health sciences lncRNA Animals Humans Aged Cell Proliferation RC705-779 Superoxide Dismutase TERRA Hydrogen Peroxide Telomere Middle Aged Catalase Idiopathic Pulmonary Fibrosis Mitochondria 3. Good health IPF A549 Cells Case-Control Studies Female RNA Interference RNA, Long Noncoding Reactive Oxygen Species Research Article
DOI: 10.1186/s12890-017-0516-1 Publication Date: 2017-12-02T03:51:03Z
ABSTRACT
Aging is a known risk factor of idiopathic pulmonary fibrosis (IPF). However, the pathogenic mechanisms underlying effects advanced aging remain largely unknown. Telomeric repeat-containing RNA (TERRA) represents type long noncoding RNA. In this study, regulatory roles TERRA on human telomeres and mitochondria IPF epithelial injury model were identified. Blood samples collected from patients with (n = 24) matched control individuals 24). The significance clinical research expression correlated was assessed. levels in vivo vitro determined through quantitative real-time polymerase chain reaction analysis. Telomerase activity observed using fluorescent TRAP assay kit. functions telomeres, mitochondria, associated genes analyzed interference TERRA. significantly increased peripheral blood mononuclear cells patients. also exhibited direct inverse correlation percentage predicted force vital capacity, which physiological indicator fibrogenesis during progression. This finding confirmed vitro. can ameliorate telomeres; mitochondria; genes; components such as telomerase reverse transcriptase, telomerase, cell nuclear antigen, cyclin D1; mitochondria-associated E genes, including MMP Bcl-2 family. improve oxidative-stress-associated reactive oxygen species, superoxide dismutase, catalase, apoptosis-related cytochrome c, caspase-9, caspase-3. regulation pathogenesis identified for first time. results may provide valuable insights discovery novel biomarker or therapeutic approach treatment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (49)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....